Alcon AG | ALC - Cost Of Sales

Stock Price
60.74
Daily Change
-0.60 -0.98%
Monthly
-6.03%
Yearly
-26.20%
Q1 Forecast
60.90

Alcon AG reported $1.16B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AstraZeneca USD 2.8B 328M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Essilor EUR 5.31B 2.79B Jun/2025
Fresenius EUR 4.19B 62M Sep/2025
Fresenius Medical Care EUR 3.64B 65.63M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.39B 65M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Sonova Holding CHF 539.4M 11.5M Dec/2025
UCB EUR 901M 50M Dec/2024